Indication

Raised seborrheic keratosis

Raised seborrheic keratosis refers to an elevated, benign cutaneous neoplasm of the integumentary system arising from the clonal proliferation of immature epidermal keratinocytes. Read more about Raised seborrheic keratosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Raised seborrheic keratosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Raised seborrheic keratosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Raised seborrheic keratosis.

Raised seborrheic keratosis refers to an elevated, benign cutaneous neoplasm of the integumentary system arising from the clonal proliferation of immature epidermal keratinocytes.

Most frequently presenting in middle-aged and older adults, lesions typically develop on sun-exposed or trunk areas—such as the face, neck, chest, and back—while characteristically sparing the palms and soles.

Clinically, these lesions are distinguished by well-demarcated, exophytic papules or plaques with a hyperkeratotic, waxy, or verrucous texture that imparts a characteristic "stuck-on" appearance, ranging in pigmentation from tan or yellow to deep brown or black.

Histopathologically, they exhibit marked epidermal thickening (acanthosis), hyperkeratosis, papillomatosis, and prominent keratin-filled invaginations known as pseudo-horn cysts.

Personalize your experience

Follow Raised seborrheic keratosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it